Diagnosis and Management of Diabetic Eye Disease, Part 4 of 7
This week's Homerun Slides cover eye diseases including Efferent Cranial Neuropathy, Glaucoma, AION and Retinal Vascular Occlusion....
Diagnosis and Management of Diabetic Eye Disease, Part 3 of 7
This week we present PART 3 of our series on the Diagnosis and Management of Diabetic Eye Disease, focusing on cataracts and keratopathy....
Diagnosis and Management of Diabetic Eye Disease, Part 2 of 7
This week we continue our special series on Diabetic Eye Disease with the second set of slides from Paul Chous....
Diagnosis and Management of Diabetic Eye Disease, Part 1 of 7
Facts of Diabetic Eye Disease: another American becomes legally blind from diabetic retinopathy every 30 minutes. There is no independent tracking of irreparable vision loss from other eye diseases commonly associated...
If your diabetes patients have sleep apnea, they may also have hypertension....
Diagnosis and Management of Diabetic Eye Disease, Part 7 of 7
This week we conclude out special seven part from Dr. Paul Chous with slides on the newest therapies for Diabetic Retinopathy....
Diagnosis and Management of Diabetic Eye Disease, Part 6 of 7
This week's slides on Diabetic Eye Disease cover the Staging of Diabetic Macular Edema, Referral & Follow-up for DR, Treatment of DR-PRP, Treatment of DR - Vitrectomy, and Treatment of...
Diagnosis and Management of Diabetic Eye Disease, Part 5 of 7
From Part 5 of our series on diabetic eye disease: "Chronic hyperglycemia unleashes a progressive cascade of events: Endothelial pericyte loss; RGC death; Increased vascular permeability; Capillary;...
Diagnosis and Management of Diabetic Eye Disease, Part 4 of 7
This week's Homerun Slides cover eye diseases including Efferent Cranial Neuropathy, Glaucoma, AION and Retinal Vascular Occlusion....
Diagnosis and Management of Diabetic Eye Disease, Part 3 of 7
This week we present PART 3 of our series on the Diagnosis and Management of Diabetic Eye Disease, focusing on cataracts and keratopathy....
Diagnosis and Management of Diabetic Eye Disease, Part 2 of 7
This week we continue our special series on Diabetic Eye Disease with the second set of slides from Paul Chous....
Diagnosis and Management of Diabetic Eye Disease, Part 1 of 7
Facts of Diabetic Eye Disease: another American becomes legally blind from diabetic retinopathy every 30 minutes. There is no independent tracking of irreparable vision loss from other eye diseases...
Diagnosis and Management of Diabetic Neuropathies, Part 5 of 5
This week we finish up our Homerun Slides series from Dr. Aaron Vinik....
Diagnosis and Management of Diabetic Neuropathies, Part 4 of 5
This week's slide collection courtesy Dr. Aaron Vinik, includes coverage of the advantages of fMRI scans and the most commonly used pain scales....
Diagnosis and Management of Diabetic Neuropathies, Part 3 of 5
"On inspection the feet may look normal. There may be autonomic features of dry skin; distended veins that fail to collapse on raising the feet first described by my mentor Professor John Ward, There may be...
Diagnosis and Management of Diabetic Neuropathies, Part 2 of 5
This week we continue Dr. Aaron Vinik's slide series on Diabetic Neuropathies....
Diagnosis and Management of Diabetic Neuropathies, Part 1 of 5
"If King Hattusili III is cured from the fire that burns his feet, I will give a golden cup with a handle of lapis lazuli to Goddess Ningal!" -- attributed to Queen Puduhepa, approx 1250 BC....
This week, we wrap up our seven part series of Homerun Slides on Incretins with a discussion of Incretin Therapy and Type 2 Diabetes Mellitus...
Incretins, Part 6 of 7
This week's slide set includes slides on GLP-1 and the Central Nervous System, the Cardiac Actions of GLP-1, and the Emerging Roles of Bioactive GLP-1 Metabolites, plus more....
Incretins, Part 5 of 7
In this week's Homerun Slides, Incretins, Part 5 of 6, we review the tissue-specific differences in the mechanisms of action of GLP-1 analogs, DPP-4 inhibitors, and GLP-1R agonists and also discuss the...
The Role of DPP-IV Inhibitors in the Management of Type 2 Diabetes
In this Special Edition on DPP-IV Inhibitors, we present a set of our Homerun Slides focused on The Role of DPP-IV Inhibitors in the Management of Type 2 Diabetes....
Incretins, Part 3 of 7
This week we continue our six part series on Incretins with Homerun Slides focused on Sitagliptin....
Incretins, Part 2 of 7
This week with Part 2 of our new Incretins series of Homerun Slides, we cover "Incretin Physiology in Type 2 Diabetes Mellitus" and "GLP-1 & GIP Secretion in Type 2 Diabetes...
Incretins, Part 1 of 7
This first of seven sets of Homerun Slides begins with GLP-1 physiology, then examines the actions of DPP-4 inhiitors and GLP-1R agonists, plus....
Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 5 of 5
This week we conclude our five-part series of Homerun Slides on Pathophysiology in the Treatment of Type 2 Diabetes: New Agents. This week's slides include coverage of Liraglutide and...
Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 4 of 5
This week we continue with Part 4 of our series of Homerun Slides on Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents. Slides this week cover Exenatide, a synthetic version of...
Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 3 of 5
We continue this week with our Homerun Slides series on Pathophysiology in the Treatment of Type 2 Diabetes: Newer...
Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 2 of 5
This week we continue our series of Homerun Slides on Pathophysiology in the Treatment of Type 2 Diabetes: New Agents with information on Colesevelam....
Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 1 of 5
This week we begin a new five-part Homerun Slides series on Pathophysiology in the Treatment of Type 2 Diabetes focusing on Newer Agents, including Bromocriptine....
GLP-1 Effectiveness, Mechanisms of Action and Potential, Part 4 of 4
This week we wrap-up our four part series on GLP-1 Agonists. Topics covered this week include: "Treatment with Exenatide does not impair the counterregulatory glucagon response," "Incretin-related...
GLP-1 Effectiveness, Mechanisms of Action and Potential, Part 3 of 4
This week, we present Part 3 of a series of 4 Homerun Slide collections covering GLP-1 Agonist therapy. This week's slides present findings on the therapeutic effects of GLP-1, GLP-1...
GLP-1 Effectiveness, Mechanisms of Action and Potential, Part 2 of 4
This week, we continue with Part 2 of our Homerun Slides series on GLP-1 Agonist Therapy....
GLP-1 Effectiveness, Mechanisms of Action and Potential, Part 1 of 4
Topics covered include the clinical effects of GLP-1 agonists and DPP-4 inhibitors stemming from incretin action, and the role of glucagon in glucose intolerance and effects of GLP-1 based drugs on plasma glucagon....
This graph compares the incidence of type 1 and type 2 diabetes among children and adolescents younger than 20 years by age group and race/ethnicity. In the year 2002–2005, among children younger than 10 years,...
In this week's set of Homerun Slides, we review AGEs and their relation to complications of diabetes including retinopathy, nephropathy, neuropathy and macrovascular disease....
Overview of AGEs, Part 1 of 4
This week we begin a new Homerun Slides series on advanced glycation end-products (AGEs) focusing on gaining insight into understanding the formation of (AGEs), their overall impact on diabetic patients,...
Incretins, Part 4 of 7
In this week's Homerun Slides, we cover DPP-IV inhibitors including a comparison of effects with GLP-1 receptor agonists....
Obesity and Socioeconomic Status in Adults
Of the approximately 72 and a half million adults who are obese, 41% (about 30 million) have incomes at or above 350% of the poverty level, 39% (over 28 million) have incomes between 130% and 350% of the poverty level,...
Shared Medical Appointments Presentation Slides, Part 2 of 2
"First, we will take a look at what in today's practice environment is stimulating a great deal of interest in the shared medical appointment concept. Next, we will provide an overview of shared medical...
Shared Medical Appointments Presentation Slides, Part 1 of 2
"At this meeting, we are examining a concept called shared medical appointments, which are frequently referred to as “SMAs.” SMAs are being adopted by physicians with medical groups and other health...
Cost-Effectiveness Strategies, Part 4 of 4
A pooled analysis of the data from the 3 pivotal trials showed reductions in A1C and LDL-C when Welchol was added to metformin-based, sulfonylurea-based, and insulin-based therapies in patients with type 2 diabetes. In...
Cost-Effectiveness Strategies, Part 3 of 4
The ACE/AACE road map for the achievement of glycemic goals in patients with diabetes recommends a wide range of therapies, including oral drugs, incretin mimetics, and insulin for the achievement of glycemic...
Cost-Effectiveness Strategies, Part 2 of 4
The systems in which most physicians work do not allow sufficient time for providing evidence-based medicine at every visit, to make sure patients understand the evidence, and to encourage patients to incorporate...
Cost-Effectiveness Strategies, Part 1 of 4
Evaluation of the Kaiser Permanente Northern California population indicated that patients with diabetes are also very likely to have both dyslipidemia and hypertension....
Navigate through our listing of Homerun Slides: Clinical presentation library articles here.
133
Total articles for Homerun Slides: Clinical presentation library
DISCLAIMER: The content of this Website is independent of the views of our advertisers and sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.
Copyright @ 1999-2013 Diabetes In Control, Inc.. All rights reserved.
